Lung Carcinoma: Clinical Trials

13 trials for Lung Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 recruiting, 3 completed, 2 active not recruiting, 1 not yet recruiting. 13 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 213Recruiting 5, Completed 3, Active not recruiting 2, Not yet recruiting 1, Unknown 1, Withdrawn 1
Phase 11Recruiting 1

Follow Lung Carcinoma: new trials by email Literature Review of Lung Carcinoma trials Research Report on Lung Carcinoma

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing the SurVaxM Vaccine for Lung Cancer Prevention
Biospecimen Collection, Montanide ISA 51 VG, Questionnaire Administration - Lung Carcinoma
Phase 2Not yet recruitingNational Cancer Institute (NCI)802026-10-012026-08-26
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Cancer Therapeutic Procedure, Questionnaire Administration - Amyloidosis, Basal Cell Carcinoma
Phase 2RecruitingMayo Clinic272025-12-182026-09-30
A Study of SKB518 in Patients With Lung Cancer
SKB518, Tislelizumab, Carboplatin - Lung Carcinoma
Phase 2RecruitingSichuan Kelun-Biotech Biopharmaceutical Co., Ltd.1922025-08-292026-05-08
Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal, Gynecological, Breast, or Lung Cancer
Biospecimen Collection, Oligo-fucoidan, Placebo Administration - Malignant Digestive System Neoplasm, Malignant Female Reproductive System Neoplasm
Phase 2RecruitingMayo Clinic342025-03-062026-10-16
Oral Iloprost for the Prevention of Lung Cancer In Former Smokers
Biospecimen Collection, Bronchial Brush Biopsy, Bronchoscopy - Bronchial Epithelial Dysplasia, Chronic Obstructive Pulmonary Disease
Phase 2WithdrawnNational Cancer Institute (NCI)2024-06-012024-05-17
Evaluation of Canakinumab in High-Risk Former-Smokers
Biospecimen Collection, Bronchoscopy, Canakinumab - Cigarette Smoking-Related Carcinoma, Lung Carcinoma
Phase 2CompletedPeter Shields412024-03-112026-07-07
Metformin for Chemoprevention of Lung Cancer in Overweight or Obese Individuals at High Risk for Lung Cancer
Biopsy, Biospecimen Collection, Bronchoscopy - Lung Carcinoma
Phase 2Active not recruitingNorthwestern University502022-09-092026-11-13
Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial
Canakinumab, Quality-of-Life Assessment - Lung Carcinoma, Stage I Lung Cancer AJCC v8
Phase 2RecruitingM.D. Anderson Cancer Center502021-07-202026-06-12
Efficacy and Safety of Apatinib as Third-line Therapy for Primary Pulmonary Lymphoepithelioid Carcinoma
Apatinib - Lung Carcinoma
Phase 2UnknownGuangzhou Institute of Respiratory Disease332018-10-192018-10-24
Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery
Near-Infrared Fluorescence Imaging, Panitumumab-IRDye800, Pharmacokinetic Study - Lung Carcinoma, Metastatic Malignant Neoplasm in the Lung
Phase 1 / Phase 2RecruitingStanford University302018-07-192026-10-05
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Adavosertib, Afatinib, Afatinib Dimaleate - Advanced Lymphoma, Advanced Malignant Solid Neoplasm
Phase 2Active not recruitingNational Cancer Institute (NCI)64522015-08-172026-11-12
18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules
Computed Tomography, fluorodeoxyglucose F-18, Fluorine F 18 L-glutamate Derivative BAY94-9392 - Lung Carcinoma, Solitary Pulmonary Nodule
Phase 2CompletedVanderbilt-Ingram Cancer Center462015-06-162022-10-19
Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current Smokers
Aspirin, Laboratory Biomarker Analysis, Placebo - Lung Carcinoma, Tobacco Use Disorder
Phase 2CompletedNational Cancer Institute (NCI)542014-06-012018-08-29

Narrower conditions

Lung Neoplasms (13)  ·  Breast Neoplasms (3)  ·  Carcinoma, Hepatocellular (2)  ·  Carcinoma, Renal Cell (2)  ·  Colorectal Neoplasms (2)  ·  Endometrial Neoplasms (2)  ·  Melanoma (2)  ·  Multiple Myeloma (2)  ·  Ovarian Neoplasms (2)  ·  Pancreatic Neoplasms (2)  ·  Prostatic Neoplasms (2)  ·  Urinary Bladder Neoplasms (2)  ·  Uterine Cervical Neoplasms (2)  ·  Amyloidosis (1)  ·  Carcinoma, Basal Cell (1)

Broader conditions

Lung Diseases (13)  ·  Neoplasms (13)  ·  Neoplasms by Site (13)  ·  Respiratory Tract Diseases (13)  ·  Respiratory Tract Neoplasms (13)  ·  Thoracic Neoplasms (13)  ·  Breast Diseases (3)  ·  Digestive System Diseases (3)  ·  Digestive System Neoplasms (3)  ·  Gastrointestinal Diseases (3)  ·  Skin Diseases (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Adenocarcinoma (2)  ·  Adnexal Diseases (2)  ·  Blood Protein Disorders (2)

Interventions

Specimen Handling (6)  ·  Bronchoscopy (3)  ·  Biopsy (2)  ·  Magnetic Resonance Spectroscopy (2)  ·  canakinumab (2)  ·  2-(3-(2-(1-isopropyl-3-methyl-1H-1,2-4-triazol-5-yl)-5,6-dihydrobenzo(f)imidazo(1,2-d)(1,4)oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide (1)  ·  2C4 antibody (1)  ·  4-(3-fluoropropyl)glutamic acid (1)  ·  AZD4547 (1)  ·  Ado-Trastuzumab Emtansine (1)  ·  Afatinib (1)  ·  Antineoplastic Protocols (1)  ·  Aspirin (1)  ·  CT-P6 (1)  ·  Carbon Monoxide (1)

Sponsors

National Cancer Institute (NCI) (4)  ·  Mayo Clinic (2)  ·  Guangzhou Institute of Respiratory Disease (1)  ·  M.D. Anderson Cancer Center (1)  ·  Northwestern University (1)  ·  Peter Shields (1)  ·  Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (1)  ·  Stanford University (1)  ·  Vanderbilt-Ingram Cancer Center (1)

Countries

United States (10)  ·  China (2)  ·  Canada (1)  ·  Guam (1)  ·  Puerto Rico (1)

Top investigators

Saikrishna S Yendamuri (2)  ·  Chirayu Shah, MD (1)  ·  Jianjun Zhang (1)  ·  Keith T Flaherty (1)  ·  Linda Garland (1)  ·  Natalie Lui (1)  ·  Peter G Shields, MD (1)  ·  Roxana S. Dronca, MD (1)  ·  York E Miller (1)  ·  Zoey I. Harris, MD (1)

Results publications

PMID 26586415, PMID 32463741, PMID 33048619, PMID 35133871, PMID 35138919, PMID 36351402, PMID 37053535, PMID 37322121, PMID 37934000, PMID 38591867, PMID 39666929, PMID 39693587, PMID 39913886, PMID 40865033, PMID 41066729

NIH funding

P30CA060553 (3), UG1CA242643 (3), N01CN00031 (1), P30CA023074 (1), P30CA068485 (1), U10CA180820 (1), U24CA196172 (1)